Rein Therapeutics Inc.

RNTX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016
Assets
Cash & Equivalents $11.9M $20.7M
Accounts Receivable — —
Inventory — —
Total Current Assets $51.8M $21.1M
Property, Plant & Equipment $154.0K $107.0K
Goodwill — —
Intangible Assets (Excl. Goodwill) — —
Total Assets $52.7M $22.0M
Liabilities
Accounts Payable $1.6M $2.0M
Total Current Liabilities $4.9M $4.1M
Long-Term Debt — —
Total Liabilities $4.9M $4.1M
Stockholders' Equity
Retained Earnings $-136.9M $-114.3M
Total Stockholders' Equity $47.8M $-111.8M
← Newer Page 2 of 2 Older →